FDA advisers back over-the-counter use of birth control pill
The committee members urged the agency to move quickly to improve access to Perrigo’s contraception pill.
The committee members urged the agency to move quickly to improve access to Perrigo’s contraception pill.
The offer from a group of private equity firms comes after a series of ups and downs for Syneos, which was formed through the 2017 merger of contract research firms InVentiv Health and INC Research.
By selling its Brand New Day and Central Health MA plans, Bright Health, which would no longer be in the insurance business following the sale, intends to focus on its consumer care products, CFO Cathy Smith said.
The insurer plans to exit the state this year after consistently recording medical loss ratios over 100%, executives said on an earnings call.
The potential filing comes after Envision has struggled in recent years, including in legal battles with UnitedHealthcare.
Vaccines, which have been crucial to curbing the threat of the virus, will remain free for the vast majority of people in the U.S., but over-the-counter tests will no longer be covered for most.
The head of the agency said the models are “ushering in the revolution that many of us were hoping for,” but cautioned that the sector will need to be regulated appropriately.
The Monday lawsuit seeks to remove safety restrictions on mifepristone or, alternatively, prevent further altering of access to the drug.
The medical credit card industry has expanded in recent years as healthcare providers promoted the cards to patients, CFPG said in a report.
The group purchasing organization lowered its revenue outlook last week due to softer demand from its customers amid excess inventory levels.